Research Collaborations

Our latest Insights

• Boston University Questrom School of Business Named Among Best Business Schools & MBA Programs
  by Shannon Light
  Questrom was recognized as a top-30 Part-Time MBA Program and a top-50 Business School by U.S. News & World Report BOSTON–(BUSINESS WIRE)–Boston University Questrom School of Business announced today that it has risen multiple spots in this year’s U.S. News & World Report rankings. Questrom now ranks at No. 29 among Part-Time MBA Programs (up from No. 33), and No. 46 among Best […]
• The Business of Higher Education: Challenges, Change, and the Road Ahead 
  by Susan Fournier
  Boston University's Questrom School of Business was a presenting partner at a recent Boston Business Journal event, gathering education leaders, business professionals, and policy experts for a vital and thought-provoking discussion on the future of higher education. With the backdrop of recent federal pressures and funding threats, the tone of the discussion was frank: higher […]
• 13 Boston University Questrom School of Business Faculty Recognized As Top-Cited Scientists for Career-Long Impact 
  by Paul Carlile
  A study led by researchers at Stanford University and published annually by Elsevier identifies the world’s most impactful researchers, ranking the top 2% of scientists across various fields. The rankings are based on standardized citation metrics, including h-index, co-authorship-adjusted hm-index, citations by authorship position, and a composite indicator. 

Our latest Insights

• Why have car insurance premiums been increasing over the past years? 
  by Pearl Steinbuch
  April 2025 WalletHub recently published insight featuring Pearl Steinbuch, Senior Lecturer of Markets, Public Policy, and Law, discussing the factors contributing to auto insurance premiums rising.
• Trump looking at cutting US drug prices to international levels, sources say 
  by Rena Conti
  April 22, 2025  Reuters recently published an article featuring Rena Conti, Associate Professor of Markets, Public Policy, and Law, discussing a controversial policy under consideration by the Trump administration, tying U.S. drug prices to those in other developed countries, a strategy known as international reference pricing.
• Small businesses in the US may take the brunt of tariffs 
  by Greg Stoller
  April 22, 2025  SupplyChainDive recently published an article featuring Greg Stoller, Master Lecturer of Strategy and Innovation, discussing how small U.S. businesses, especially boutiques, direct-to-consumer brands, and local manufacturers, are struggling to navigate the Trump administration’s shifting and steepening tariff policies.